AR085409A1 - Firmas microbianas como indicadores de exposicon a radiacion - Google Patents

Firmas microbianas como indicadores de exposicon a radiacion

Info

Publication number
AR085409A1
AR085409A1 ARP120100623A AR085409A1 AR 085409 A1 AR085409 A1 AR 085409A1 AR P120100623 A ARP120100623 A AR P120100623A AR 085409 A1 AR085409 A1 AR 085409A1
Authority
AR
Argentina
Prior art keywords
radiation exposure
microbiota
sample collection
correlates
levels
Prior art date
Application number
Other languages
English (en)
Original Assignee
Tricorder Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tricorder Diagnostics Llc filed Critical Tricorder Diagnostics Llc
Publication of AR085409A1 publication Critical patent/AR085409A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of Radiation (AREA)

Abstract

Reivindicación 1: Un método para identificar y/o caracterizar la exposición a la radiación, que comprende: proporcionar una firma microbiana de referencia que se correlaciona con una o varias características de la exposición a la radiación; y determinar una firma microbiana presente en una muestra de microbiota de un individuo cuya exposición a la radiación se debe identificar o caracterizar.Reivindicación 18: Un método para definir una firma microbiana que se correlaciona con un aspecto de la exposición a la radiación, donde el método comprende los pasos de: determinar un primer conjunto de niveles de uno o varios tipos de microbios o componentes o productos de ellos en una primera recolección de muestras de microbiota, donde cada muestra de la primera recolección de muestras de microbiota comparte una característica común de exposición a la radiación; determinar un segundo conjunto de niveles del uno o varios tipos de microbios o componentes o productos de ellos en una segunda recolección de muestras de microbiota, donde la segunda recolección de muestras de microbiota no comparte la característica común de exposición a la radiación, pero que de otro modo es comparable con el primer conjunto de muestras de microbiota; identificar una firma microbiana que comprende niveles dentro del primer o el segundo conjunto que se correlaciona con la presencia o ausencia de la característica común de exposición a la radiación.
ARP120100623 2011-02-25 2012-02-24 Firmas microbianas como indicadores de exposicon a radiacion AR085409A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161446696P 2011-02-25 2011-02-25
US201161451930P 2011-03-11 2011-03-11
US201161479786P 2011-04-27 2011-04-27
US201161491452P 2011-05-31 2011-05-31

Publications (1)

Publication Number Publication Date
AR085409A1 true AR085409A1 (es) 2013-10-02

Family

ID=46000317

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120100623 AR085409A1 (es) 2011-02-25 2012-02-24 Firmas microbianas como indicadores de exposicon a radiacion

Country Status (3)

Country Link
AR (1) AR085409A1 (es)
TW (1) TW201247875A (es)
WO (1) WO2012116289A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP2951283A4 (en) 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
KR102222273B1 (ko) 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
KR102379658B1 (ko) 2013-11-25 2022-03-28 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CN107075588B (zh) 2014-10-21 2023-03-21 普梭梅根公司 用于微生物组来源的诊断和治疗的方法及系统
WO2016193846A2 (en) * 2015-05-29 2016-12-08 Koninklijke Philips N.V. Degenerate primer sets
CN106991265B (zh) * 2016-01-20 2019-12-24 华北电力大学 核电厂面源辐射源强逆推方法及面源辐射源强逆推系统
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
CN111315899A (zh) * 2017-09-06 2020-06-19 普梭梅根公司 与鼻部微生物组相关的鼻有关表征
CN109738929B (zh) * 2018-12-03 2022-10-21 中国辐射防护研究院 一种基于居民食物最大消费量的剂量估算方法及系统
WO2022032282A1 (en) * 2020-08-06 2022-02-10 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Methods and reagents for microbiome analysis

Also Published As

Publication number Publication date
WO2012116289A3 (en) 2012-11-01
TW201247875A (en) 2012-12-01
WO2012116289A2 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
AR085409A1 (es) Firmas microbianas como indicadores de exposicon a radiacion
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
CO2019012771A2 (es) Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos
BR112014018995A2 (pt) Sistemas para executar ensaio automatizado
CR20150151A (es) Sistema de control de elución de rubidio
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
CY1121916T1 (el) Βιοδεικτες micro-rna για την ταυτοποιηση του κινδυνου και/ή τη διαγνωση του ογκου στον πνευμονα
MX2016013255A (es) Metodos y composiciones para detectar proteinas mal plegadas.
CR20130657A (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
BR112018015211A2 (pt) indicadores biológicos
GB201207297D0 (en) Analytical methods and arrays for use in the same
BR112017006315A2 (pt) agente terapêutico, uso de um agente terapêutico, métodos in vitro para determinar se um sujeito com melanoma tem um risco maior de desenvolver metástase, de determinação de um regime de tratamento para um sujeito que sofre de melanoma, de tratamento de um sujeito que sofre de melanoma, ensaio in vitro para predizer o risco aumentado de metástase e kits
BR112013030271A2 (pt) método e aparelho para classificar múltiplos estados de dispositivo
BR102012002812A8 (pt) método para determinar a influência de uma variável em um fenômeno
AR080361A1 (es) Identificacion, evaluacion y terapia de canceres con resistencia innata o adquirida a inhibidores de quinasa del linfoma anaplasico (alk)
CY1120220T1 (el) Μεθοδοι και κυτια για προσδιορισμο της καταστασης λοιμωξης απο φυματιωση
BR112012020491A2 (pt) processo para a preparação de forma alfa de mesilato de imatinib.
AR096465A1 (es) Método y dispositivo para la corrección de desviaciones de intensidad en un espectrómetro
BR112017000750A2 (pt) gerenciamento de interferência em um ambiente de interferência intermitente
AU346000S (en) Biochemical test card for use in automated microbial testing system
GB2539150A (en) Methods for inspecting channel regions in absorbent structures in absorbent articles
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
BR112016002668A2 (pt) métodos e kits para prognosticar o risco de ter uma doença ou evento cardiovasculares
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
MY181007A (en) Scale drop disease (sdd) causative virus and derivatives thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure